- Tools for journalists
- Join us
As most European countries start to re-emerge from lockdown, it’s becoming clear that we aren’t getting “back to normal” anytime soon. So, how is COVID-19 changing our lives? How did our daily routine and consumption change during the lockdown, and what changes may stay with us for a long time?
According to researchers from the Croatian Institute of Public Finance, even if the health crisis improves very quickly, a difficult year lies ahead for the country.
How did COVID-19 lockdown impacted all four main economic confidence indicators? Our Stats Monitor makes it possible to monitor the evolution of industrial, consumer, construction and retail confidence over time.
You can explore the pedestrian occupation, road traffic and flights of European capitals in this data visualization, which shows the current percentage of occupation compared to the normal levels before the coronavirus lockdown.
The south slows down and the north carries on. On Friday, April 17, the number of people on the streets in Europe rose again to over 40% for the first time in the last month
Our thematic focus this month is entirely on the legal and democratic challenges that the pandemic is posing to our societies. In particular, we look at how fundamental rights may be threatened by some emergency measures that are adopted or discussed in Europe.
We inaugurate a new format for EDJNet's newsletter: once a month, we send out a special newsletter with a thematic focus, while the standard newsletter comes out every two weeks. Here's the March focus.
Not everyone is traveling to work these days, many are working from home. We have more time to watch things, to listen and read. Music services should be doing well out of this, but the data suggests just the opposite.
EU heads of state and government failed to agree on a united response to the economic crisis triggered by COVID-19. Yet after the measures taken by the European Central Bank, there is no longer urgency to enact a measure like eurobonds.
The COVID-19 outbreak has revived fears over acute drug shortages in Europe, sparking calls to repatriate the production of pharmaceutical ingredients from China. But rebuilding capacity would take years, if it were even possible.